Medical technology company Motus GI Holdings Inc (NASDAQ:MOTS) saw its stock go into a upward spiral on Tuesday after it made a significant announcement.
Market Action:
On Tuesday, MOTS stock moved up 18.17% at $0.7161 with more than 7.33 million shares, compared to its average volume of 575.90K shares. The stock has moved within a range of $0.6125 – 0.7567 after opening the trade at $0.6200.
Announces Presentation of Results from Independent Study of Pure-Vu System in IBP Patients at the 2021 ACG Annual Scientific Meeting
Yesterday, the company was in the news after it made an announcement with regards to the results from the single center study that had been conducted on the Pure-Vu System. The results from the study were feature in poster presentation that had taken place 2021 American College of Gastroenterology (ACG) Annual Scientific Meeting. While it was a major development for the company, the news did seem to excite investors much and the Motus stock jumped by as much as 18% as a consequence.
While the market did not react kindly to the news, it goes without saying that in the larger scheme of things it was an important breakthrough for Motus. The Chief Executive Officer and Director of the company Tim Moran spoke about the development. He stated that everyone at the company was excited by the development since the test had been conducted in the form of a ‘real world, independent’ study. At this point in time, it is perhaps necessary for investors to keep a close eye on the stock and related developments.
